Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 2.15B | 1.95B | 1.82B | 1.86B | 1.81B |
Gross Profit | 2.00B | 1.66B | 754.10M | 884.30M | 874.30M |
EBITDA | 1.19B | 992.70M | 1.18B | 1.19B | 1.16B |
Net Income | 264.70M | 126.90M | 204.90M | -56.80M | 453.40M |
Balance Sheet | |||||
Total Assets | 16.77B | 15.65B | 14.53B | 14.44B | 14.18B |
Cash, Cash Equivalents and Short-Term Investments | 1.67B | 1.40B | 340.40M | 240.90M | 744.10M |
Total Debt | 10.79B | 10.00B | 8.44B | 7.98B | 8.45B |
Total Liabilities | 14.77B | 13.60B | 12.02B | 11.48B | 11.15B |
Stockholders Equity | 2.00B | 2.06B | 2.51B | 2.96B | 3.03B |
Cash Flow | |||||
Free Cash Flow | -79.90M | -19.00M | 93.50M | 305.90M | 221.80M |
Operating Cash Flow | 918.10M | 745.10M | 787.50M | 934.40M | 865.80M |
Investing Cash Flow | -987.20M | -731.40M | -593.40M | -639.70M | -555.70M |
Financing Cash Flow | 358.80M | 1.04B | -85.00M | -809.70M | -89.70M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
75 Outperform | £20.28B | 17.09 | 12.29% | 2.30% | -3.11% | -31.10% | |
72 Outperform | £7.40B | 6.04 | 32.10% | 3.92% | -24.74% | -63.34% | |
71 Outperform | €12.96B | 45.74 | 11.98% | 4.76% | 1.44% | 6.41% | |
71 Outperform | £51.22B | 17.03 | 8.35% | 5.91% | -7.42% | 5.84% | |
63 Neutral | £8.02B | 34.46 | 12.73% | 5.48% | 3.78% | 50.18% | |
62 Neutral | £7.56B | 28.30 | 13.05% | 6.24% | 10.04% | ― | |
57 Neutral | £2.31B | ― | -4.44% | 6.01% | 15.42% | -406.43% |